{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:29:11Z","timestamp":1771356551577,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vhri.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T14:19:56Z","timestamp":1677248396000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom"],"prefix":"10.1016","volume":"35","author":[{"given":"Alex","family":"Porteous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy A.","family":"Eddowes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Drayson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Bowcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenella","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Renwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Laketic-Ljubojevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vhri.2023.01.001_bib1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.vhri.2023.01.001_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1186\/s12885-021-08280-y","article-title":"Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019","volume":"21","author":"Zhou","year":"2021","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.vhri.2023.01.001_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194788","article-title":"Myeloma: patient accounts of their pathways to diagnosis","volume":"13","author":"Howell","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vhri.2023.01.001_bib8","article-title":"Multiple myeloma: an overview of management","volume":"13","author":"Bird","year":"2019","journal-title":"Palliat Care Soc Pract"},{"issue":"1","key":"10.1016\/j.vhri.2023.01.001_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bjh.14513","article-title":"Multiple myeloma: routes to diagnosis, clinical characteristics and survival-findings from a UK population-based study","volume":"177","author":"Howell","year":"2017","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.vhri.2023.01.001_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034244","article-title":"\u2018Unpacking\u2019 pathways to lymphoma and myeloma diagnosis: do experiences align with the Model of Pathways to Treatment? Findings from a UK qualitative study with patients and relatives","volume":"10","author":"Howell","year":"2020","journal-title":"BMJ Open"},{"issue":"25","key":"10.1016\/j.vhri.2023.01.001_bib11","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.vhri.2023.01.001_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bjh.14213","article-title":"Multiple myeloma: patient outcomes in real-world practice","volume":"175","author":"Yong","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.vhri.2023.01.001_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1472-684X-12-42","article-title":"Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death","volume":"12","author":"Howell","year":"2013","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.vhri.2023.01.001_bib22","series-title":"Decision Modelling for Health Economic Evaluation (Handbooks for Health Economic Evaluation)","author":"Briggs","year":"2006"},{"issue":"7","key":"10.1016\/j.vhri.2023.01.001_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.16357","article-title":"Phase-specific and lifetime costs of multiple myeloma among older adults in the US","volume":"4","author":"Bhattacharya","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.vhri.2023.01.001_bib24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1186\/s12885-016-2835-7","article-title":"Phase-specific and lifetime costs of cancer care in Ontario, Canada","volume":"16","author":"de Oliveira","year":"2016","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.vhri.2023.01.001_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019758","article-title":"Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis","volume":"8","author":"Koshiaris","year":"2018","journal-title":"BMJ Open"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923000018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923000018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:13:31Z","timestamp":1761941611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109923000018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":13,"alternative-id":["S2212109923000018"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2023.01.001","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}